ArticleScientific reports2025
Plasmonic SPR biosensor with bayesian regression for non-invasive protein biomarker detection.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents a designed metasurface sensor for protein biomarkers detection. The design of this metasurface structure is essentially dependent on the coating of four identical figure-eight-shaped resonators of MXene through black phosphorus and graphene. Meanwhile, the performance analysis demonstrates a competitive sensitivity (395 GHz/RIU) with a linear frequency response of R² = 0.954 and protein biomarker concentration (R² = 0.956). The sensor exhibits stable performance across 0.31-0.46 THz and maintains consistent operation at incident angles up to 30°. Interestingly, this tunability is achieved through graphene chemical potential modulation, with transmittance decreasing from 97.7% to 66.7% as its value increases. Additionally, the machine learning optimization using Bayesian Ridge Regression demonstrates exceptional predictive capabilities for both refractive index variations (R² ≈ 86%) and angular dependencies (R² ≈ 96%). This integrated photonic-microfluidic sensor platform offers significant potential for early detection of neurological disorders through rapid, sensitive, and scalable brain tumor biomarker analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.